INS and obesity due to melanocortin 4 receptor deficiency: In sum, given the significant sexual dimorphism in obesity comorbidities and the renewed interest in RSG as an anti-diabetic drug, it is worthwhile to investigate whether there is a sexual dimorphism in the insulin-sensitizing effect of RSG on WAT during obesity and inflammation.